Duloxetine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Duloxetine Hydrochloride
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Duloxetine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

109 API Suppliers, 43 USDMF, 31 CEP/COS, 13 JDMF, 18 EU WC, 26 KDMF, 17 NDC API, 61 Listed Suppliers, $ API Reference Price

109 API Suppliers
43 USDMF
31 CEP/COS
13 JDMF
18 EU WC
26 KDMF
17 NDC API
61 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

35 Intermediate Suppliers

35 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

586 FDF Dossiers, 98 FDA Orange Book, 282 Europe, 42 Canada, 14 Australia, 26 South Africa, 124 Listed Dossiers

586 FDF Dossiers
98 FDA Orange Book
282 Europe
42 Canada
14 Australia
26 South Africa
124 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

3 Evonik, 1 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 15 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 6 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 39 Controlled & Modified Release, 35 Solubilizers, 34 Disintegrants & Superdisintegrants, 32 Direct Compression, 25 Granulation, 24 Thickeners and Stabilizers, 21 Taste Masking, 20 Topical, 20 Parenteral, 18 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 17 Film Formers & Plasticizers, 13 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules

80 Fillers, Diluents & Binders
75 Coating Systems & Additives
39 Controlled & Modified Release
35 Solubilizers
34 Disintegrants & Superdisintegrants
32 Direct Compression
25 Granulation
24 Thickeners and Stabilizers
21 Taste Masking
20 Topical
20 Parenteral
18 Chewable & Orodispersible Aids
17 Lubricants & Glidants
17 Film Formers & Plasticizers
13 Co-Processed Excipients
9 Empty Capsules
8 Emulsifying Agents
7 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 54 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
54 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 216 Finished Drug Prices, 14 Annual Reports

2 US Medicaid Prescriptions
216 Finished Drug Prices
14 Annual Reports

MARKET PLACE

23 APIs, 7 FDF Dossiers

23 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 6 Health Canada Patents

16 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 10 Others

3 EDQM
3 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

2 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 277 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

16 All

01 16SUN PHARM

filter Patent Number Reset all filters

16 All

01 49839626

02 410413525

03 410959982

04 411202772

filter API Patent Reset all filters

16 All

01 16Blank

filter FDF Patent Reset all filters

16 All

01 16Y

filter Expiration Date Reset all filters

16 All

01 162037-04-13

Product Main Page

01

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 10959982

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 11202772

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 11202772

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 10413525

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 10413525

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 10959982

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioAsia

Not Confirmed

SUN PHARM

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!